This is in agreement with our previous studies showing that the addition of pembrolizumab along with oncolytic adenovirus AdV5/3-D24-GM-CSF in SK-Mel-28 cells led to a stronger anti-tumor effect in comparison to single therapies [80]. Here, CSF2 is linked to neoplasm.